ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,544.59
      -0.78%
      US Tech 100
      19,135.20
      -0.23%
      Dow Jones
      40,665.02
      -1.29%
      Brent Oil
      84.285
      0.24%
      Bitcoin
      63,853.69
      -0.18%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Enliven Therapeutics Inc (ELVN)

      7. Enliven Therapeutics Inc (ELVN) Financials

      Enliven Therapeutics Inc

      Enliven Therapeutics Inc (ELVN)

      1111 Exploration Corp
      22.60
      -1.16
      (-4.88%)
      Closed July 18 4:00PM
      Delayed by 15 minutes
      22.60
      0.00
      ( 0.00% )
      Pre Market: 4:05AM
      Delayed by 15 minutes

      Enliven Therapeutics Inc Financial Summary

      The current ELVN market cap is 1.06B. The company's latest EPS is USD -1.5219 and P/E is -4.15.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -16.42M-20.13M-24.25M-22.73M-25.99M
      Net Income -14.72M-16.72M-20.77M-19.37M-22.74M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -24.12M-41.7M-51.44M-34.27M-83.53M
      Net Income -23.46M-49.22M-51.38M1.49M-71.58M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 302.87M288.5M274.04M271.87M342.78M
      Total Liabilities 11.45M9.51M12.29M25.96M25.07M
      Total Equity 291.42M278.99M261.75M245.91M317.71M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 33.3M90.84M93.65M91.96M271.87M
      Total Liabilities 4.38M6.41M7.62M1.83M25.96M
      Total Equity 28.92M84.44M86.03M90.13M245.91M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -20.84M-32.89M-48.79M-61.27M-23.36M
      Investing -31k-151.55M-187.1M-148.41M-17.89M
      Financing 237.44M234.62M234.2M234.29M90.27M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -21.88M-37.4M-46.77M-35.57M-61.27M
      Investing -24.06M-16.72M-1.63M76.52M-148.41M
      Financing 43.58M96.88M49.1M-1.23M234.29M

      Stats and Ratios

      Market Cap 1.06B
      Price to Earnings Ratio -4.15
      Price to Sales Ratio 0
      Price to Cash Ratio 2.97
      Price to Book Ratio 1.21
      Dividend Yield -

      Share Statistics

      Shares Outstanding 47.04M
      Average Volume (1 week) 326.36k
      Average Volume (1 Month) 298.81k
      52 Week Change 22.56%
      52 Week High 26.00
      52 Week Low 9.80
      Spread (Intraday) 16.15 (44.67%)

      Company Info

      Company Name Enliven Therapeutics Inc
      Address corporation trust center 1209 orange st
      wilmington, delaware 19801
      Website https://
      Industry pharmaceutical preparations (2834)